James Talton

James Talton

James Talton

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities,
Founded
1999
Raised
$66.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$28,500,000
Debt financing - 2015
$8,000,000
Debt financing - 2014
Trinity Capital Investment
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when James Talton makes some noise.